Literature DB >> 34799278

Review: Outcome measures in calcium pyrophosphate deposition.

Ken Cai1, Sara K Tedeschi2.   

Abstract

This review highlights outcomes for patients with calcium pyrophosphate deposition (CPPD) reported in prior studies and underscores challenges to assessing outcomes of this condition. Prior clinical studies of interventions for CPPD focused on joint damage and calcification on imaging tests, joint pain, swelling, and inflammatory biomarkers. Qualitative interviews with patients with CPPD and healthcare providers additionally identified flares, overall function, and use of analgesic medications as important outcomes. Imaging evidence of joint damage and calcification is likely to be outcomes in future clinical studies of CPPD, though reliability and sensitivity to change in CPPD require further testing for several imaging modalities. Challenges to outcome measurement in CPPD include questions of attribution of signs and symptoms to CPPD versus co-existing forms of arthritis, lack of therapies to prevent or dissolve calcium pyrophosphate crystal deposition, absence of validated patient- or physician-reported CPPD outcome measures, and scarcity of large cohorts in which to study outcomes of different clinical presentations of CPPD.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CPPD; Calcium pyrophosphate deposition disease; Outcome measures; Pseudogout

Mesh:

Substances:

Year:  2021        PMID: 34799278      PMCID: PMC8678359          DOI: 10.1016/j.berh.2021.101724

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  58 in total

1.  Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies.

Authors:  T Neogi; M Nevitt; J Niu; M P LaValley; D J Hunter; R Terkeltaub; L Carbone; H Chen; T Harris; K Kwoh; A Guermazi; D T Felson
Journal:  Arthritis Rheum       Date:  2006-06

2.  Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria.

Authors:  D J McCarty
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

3.  International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise.

Authors:  Marwin Gutierrez; Wolfgang A Schmidt; Ralf G Thiele; Helen I Keen; Gurjit S Kaeley; Esperanza Naredo; Annamaria Iagnocco; George A Bruyn; Peter V Balint; Emilio Filippucci; Peter Mandl; David Kane; Carlos Pineda; Andrea Delle Sedie; Hilde Berner Hammer; Robin Christensen; Maria Antonietta D'Agostino; Lene Terslev
Journal:  Rheumatology (Oxford)       Date:  2015-05-13       Impact factor: 7.580

4.  Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.

Authors:  Crystal Kleiber Balderrama; Ann K Rosenthal; Daniel Lans; Jasvinder A Singh; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

Review 5.  A critical review of the available evidence on the diagnosis and clinical features of CPPD: do we really need imaging?

Authors:  Georgios Filippou; Emilio Filippucci; Peter Mandl; Abhishek Abhishek
Journal:  Clin Rheumatol       Date:  2020-11-24       Impact factor: 2.980

Review 6.  Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management.

Authors:  Georgios Filippou; Tristan Pascart; Annamaria Iagnocco
Journal:  Curr Rheumatol Rep       Date:  2020-04-15       Impact factor: 4.592

7.  Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).

Authors:  Opetaia Aati; William J Taylor; Richard J Siegert; Anne Horne; Meaghan E House; Paul Tan; Jill Drake; Lisa K Stamp; Nicola Dalbeth
Journal:  Ann Rheum Dis       Date:  2014-08-11       Impact factor: 19.103

8.  Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force.

Authors:  Georgios Filippou; Carlo Alberto Scirè; Antonella Adinolfi; Nemanja S Damjanov; Greta Carrara; George A W Bruyn; Tomas Cazenave; Maria Antonietta D'Agostino; Andrea Delle Sedie; Valentina Di Sabatino; Mario Enrique Diaz Cortes; Emilio Filippucci; Frederique Gandjbakhch; Marwin Gutierrez; Daryl K Maccarter; Mihaela Micu; Ingrid Möller Parera; Gaël Mouterde; Mohamed Atia Mortada; Esperanza Naredo; Carlos Pineda; Francesco Porta; Anthony M Reginato; Iulia Satulu; Wolfgang A Schmidt; Teodora Serban; Lene Terslev; Violeta Vlad; Florentin Ananu Vreju; Pascal Zufferey; Panagiotis Bozios; Carmela Toscano; Valentina Picerno; Annamaria Iagnocco
Journal:  Ann Rheum Dis       Date:  2018-03-13       Impact factor: 19.103

9.  Evidence of a systemic predisposition to chondrocalcinosis and association between chondrocalcinosis and osteoarthritis at distant joints: a cross-sectional study.

Authors:  A Abhishek; S Doherty; R Maciewicz; K Muir; W Zhang; M Doherty
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-07       Impact factor: 4.794

10.  Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data.

Authors:  Sara K Tedeschi; Tianrun Cai; Zeling He; Yuri Ahuja; Chuan Hong; Katherine A Yates; Kumar Dahal; Chang Xu; Houchen Lyu; Kazuki Yoshida; Daniel H Solomon; Tianxi Cai; Katherine P Liao
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.